copper peptide · copper tripeptide-1
A short peptide carrying copper, used in skin care. No injectable medicine in the EU or US.
This site is for information and education only. It does not promote or encourage the use or purchase of the substances described and is not medical advice. Many are not authorised as medicines and their safety has not been established. We sell nothing and have no ties to sellers. For health decisions, consult a doctor.
Doping. It is not on the WADA list, but WADA also bans substances that no health authority has approved, so it may be banned.
Safety. Skin-care data do not describe injections. A 2026 review says very little is known about the safety of peptides like this one in people. Sources: study 1.
Risk of fakes. Reviews name it among peptides sold outside medical care. We found no tests of what these products contain. Sources: study 1.
| Where | Status | Checked | |
|---|---|---|---|
| PL | No approval | The European medicines database (EMA) lists no such medicine in Poland (9 October 2026). The Polish register was down, so we could not check it directly. This covers medicines, not cosmetics. Source | Not yet |
| EU | No approval | The European medicines database (EMA), which covers EU and national approvals, lists no such medicine (9 October 2026). This covers medicines, not cosmetics. Source | Not yet |
| US | No approval | The FDA drug register has no such medicine. Source | Not yet |
Scientific papers per year 2015–2025
These are search results. A count shows how much exists, not how good the studies are. 1 Nov 2026.
No effect in studies. A study of 13 people after a laser skin treatment found no clear improvement in measurements. It tested use on the skin, not injections.
What doctors, patients and companies reported to the US medicines agency (FDA), and single cases described in medical journals. A report says what happened to someone after taking the substance. It does not prove the substance caused it, and it does not say how often it happens. Reports do not change any grade.
| Most often reported | Reports |
|---|---|
| Allergic shock | 1 |
| Low blood pressure | 1 |
| Flushing | 1 |
| Slow heartbeat | 1 |
| Heavy sweating | 1 |
| Allergic reaction | 1 |
| Unable to move | 1 |
| Passing out | 1 |
Serious means the person went to hospital, their life was in danger, they were left with lasting harm, or they died. One report can list several side effects.
We found no published case of harm.
FDA reports come from openFDA, cases from a PubMed search. The editors have not read these cases yet. Titles stay in the original language. As of 3 Nov 2026.
Two pain medicine specialists go through the studies on BPC-157, TB-500, MOTS-c and GHK-Cu, the risk of contaminated products bought online, including heavy metals, and why a doctor should assess you first.
A dermatologist goes through the studies on GHK-Cu for skin, hair and wound healing. She explains how creams differ from injections and why injections are a concern: no approval for cosmetic use, few studies in people and uncertain product content.
The description has ads
| Studies | Kind of study | Who was studied | People | Duration | Dose as studied | Who paid |
|---|---|---|---|---|---|---|
| Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. | Random groups | Patients after CO2 laser skin resurfacing | 13 | 12 wk | – | Unknown |
We found these papers automatically in PubMed. The editors have not read them yet, and they do not affect any grade. Titles stay in the original language.
